HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Paris League Of Experts; ELC Names Tom Ford Leaders; Every Man Jack Gets B Corp Certified; Cosmetics News

Executive Summary

“Establishing a collective will allow us to better reach and engage with our consumers in a way that feels approachable and relatable,” says L’Oreal Paris US, which has brought on prominent makeup artists Allan Avendaño, Claudia Betancur, and Erica Taylor as the first members of its League of Experts. More cosmetics news.

You may also be interested in...



Nano-Form Cosmetic Ingredients Subject To New EU Prohibitions; Beauty News In Brief

From new cosmetic ingredient restrictions in the EU to beauty tech developments, M&A and industry leadership changes, beauty news in brief.

L’Oreal Bets On Biotech; Beautycounter Launches CEO Search; NIVEA ‘Skin Out Loud’; Cosmetics News

“Cell-free biomanufacturing is not science fiction: it is here,” says L’Oreal’s Barbara Lavernos deputy chief executive officer in charge of research, innovation and technology, on the beauty giant’s investment in Debut Biotechnology, Inc. to drive development of sustainable, next-generation active ingredients for cosmetics. More news in brief.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153670

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel